siderosis-symptoms

Symptoms of Siderosis in the Lungs

Unlike most other chronic lung diseases, siderosis does not produce obvious symptoms. In fact, people may not realize they have siderosis unless a chest X-ray reveals small nodules in the lower half of the lungs, which are the only discernable signs of this condition. Despite having little to no symptoms, however, some researchers believe lung function may be slightly compromised due to the prolonged inhalation of iron oxide fumes or dust.

While siderosis alone does not lead to noticeable symptoms, it can increase the risk of other lung conditions like emphysema and chronic obstructive pulmonary disease (COPD) that make it difficult to engage in physical activity or even perform daily actions like walking. These diseases may cause shortness of breath, persistent coughing and a reduction in overall quality of life. Traditional treatments for chronic lung disease include supplemental oxygen, medications and breathing exercises, but not everyone is able to find satisfactory symptom relief from these approaches.

The Lung Institute offers a new source of hope to patients with chronic lung diseases related to siderosis. The first center in the nation to focus exclusively on lung conditions, the Lung Institute is a leader in regenerative medicine, a minimally invasive breakthrough treatment that leverages the patient’s own cells to stimulate the body’s natural healing processes. While there is not yet a cure for emphysema, COPD and related lung diseases, cellular therapy has the potential to reduce lung inflammation and lessen the severity of symptoms in certain patients.

If you are experiencing symptoms from siderosis-related conditions, allow the Lung Institute to help you breathe easier. A member of our compassionate team will be happy to inform you about our innovative treatment and determine if cellular therapy may be right for you. To take the first step toward finding relief from your symptoms, call 888-745-6697 today.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.